Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-07-02

Clinical Trial Update: Topiramate in the Treatment of Pathological Gambling [Phase 3]

View source ↗

Summary

Phase 3 trial of topiramate for pathological gambling was terminated; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Topiramate (Topiramate)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Pathological Gambling | Phase 3 | Status: TERMINATED | Results posted: 2019-07-02